Stay updated on Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page.

Latest updates to the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer shows an updated release/version marker (from Revision v3.5.2 to Revision v3.5.3), indicating a site software/content-presentation update rather than a change to the underlying study record.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 released. This update does not alter study details, eligibility criteria, or page functionality.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision: v3.4.3 has been added and Revision: v3.4.2 has been removed.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 is now displayed. The funding-lapse notice and the v3.4.1 revision note have been removed.SummaryDifference0.5%

- Check81 days agoChange DetectedA site-wide funding-status notice and a revision update (v3.4.1, replacing v3.4.0) were added. These are administrative changes and do not alter the study content or data on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page.